Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate
Treatment with biologic medicines can, in some patients, trigger the body’s immune system to develop anti-drug antibodies. These anti-drug antibodies can reduce the effectiveness of the biologic therapy.